1. Serfling RE, Sherman IL, Houseworth WJ. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957–58, 1960 and 1963. American Journal of Epidemiology 1967; 86: 433–441.
2. Nguyen-Van-Tam JS. Epidemiology of influenza. In: Nicholson KG, Webster RG, Hay AJ eds. Textbook of Influenza. Oxford: Blackwell Sciences, 1998, pp. 181–206.
3. Nicholson KG. Human influenza. In: Nicholson KG, Webster RG, Hay AJ eds. Textbook of Influenza. Oxford: Blackwell Sciences, 1998, pp. 219–264.
4. Fleming DM. The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Communicable Disease and Public Health 2000; 3: 32–38.
5. Fleming D, Harcourt S, Smith G. Influenza and adult hospital admissions for respiratory conditions in England 1989–2001. Communicable Disease and Public Health 2003; 6: 231–237.
6. Simonsen L, et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. Journal of Infectious Diseases 1998; 178: 53–60.
7. Fleming DM, et al. The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands. European Journal of Epidemiology 1999; 15: 467–473.
8. Mufson MA, et al. Epidemiology of respiratory syncytial virus infection among infants and children in Chicago. American Journal of Epidemiology 1973; 98: 88–95.
9. Anderson LJ, Parker RA, Strikas RL. Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children. Journal of Infectious Diseases 1990; 161: 640–646.
10. Fleming DM, Cross KW. Respiratory syncytial virus or influenza? Lancet 1993; 342: 1507–1510.
11. Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiology and Infection 1996; 116: 51–63.
12. Crowcroft NS, Cutts F, Zambon MC. Respiratory syncytial virus: an underestimated cause of respiratory infection, with prospects for a vaccine. Communicable Disease and Public Health 1999; 2: 234–241.
13. Zambon MC, et al. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001; 358: 1410–1416.
14. Thompson WW, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association 2003; 289: 179–186.
15. Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. Journal of Epidemiology and Community Health 2005; 59: 586–590.
16. Agius G, et al. An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings. Journal of Medical Virology 1990; 30: 117–127.
17. Falsey AR, et al. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. Journal of the American Geriatrics Society 1992; 40: 115–119.
18. Falsey AR, et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. Journal of Infectious Diseases 1995; 172: 389–394.
19. Falsey AR, et al. Respiratory syncytial virus infection in elderly and high-risk adults. New England Journal of Medicine 2005; 352: 1749–1759.
20. Stockton J, et al. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. Journal of Clinical Microbiology 1998; 36: 2990–2995.
21. Aymard M, et al. Surveillance and impact of influenza in Europe. Groupe Regional d'Observation de la Grippe and European Influenza Surveillance Scheme. Vaccine 1999; 17 (Suppl, 1): S30–41.
22. Meerhoff TJ, et al. Harmonising the virological surveillance of influenza in Europe: results of an 18-country survey. Virus Research 2004; 103: 31–33.
23. Fleming DM, et al. Respiratory illness associated with influenza and respiratory syncytial virus infection. Archives of Disease in Childhood 2005; 90: 741–746.
24. Fleming DM. Weekly Returns Service of the Royal College of General Practitioners. Communicable Disease and Public Health 1999; 2: 96–100.
25. Campbell MJ, Gardner MJ. Calculating confidence intervals for some non-parametric analyses. In: Gardner MJ, Altman DG eds. Statistics with Confidence: Confidence Intervals and Statistical Guidelines. London: British Medical Association, 1989, pp. 71–79.
26. Sunderland RS, Fleming DM. Continuing decline in acute asthma episodes in the community. Archives of Disease in Childhood 2004; 89: 282–285.
28. Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clinical Infectious Diseases 2001; 33: 792–796.
29. Bustamante-Calvillo ME, et al. Molecular detection of respiratory syncytial virus in postmortem lung tissue samples from Mexican children deceased with pneumonia. Pediatric Infectious Disease Journal 2001; 20: 495–501.
30. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet 2003; 361: 2226–2234.
31. Djelantik IG, et al. Incidence and clinical features of hospitalization because of respiratory syncytial virus lower respiratory illness among children less than two years of age in a rural Asian setting. Pediatric Infectious Disease Journal 2003; 22: 150–157.
32. Stensballe LG, Devasundaram JK, Simoes EA. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatric Infectious Disease Journal 2003; 22: S21–32.
34. Jefferson T, et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005; 366: 1165–1174.
35. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 1998; 352: 1877–1881.
36. Makela MJ, et al. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. Journal of Infection 2000; 40: 42–48.
37. Zambon M, et al. Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza. Archives of Internal Medicine 2001; 161: 2116–2122.